Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease
- PMID: 19948621
- DOI: 10.1542/peds.2008-3087
Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease
Abstract
Objective: Oxidative stress is increased in nonalcoholic fatty liver disease (NAFLD). Variants in the UGT1A1 gene contribute to increased bilirubin levels, and bilirubin can act as an antioxidant. We hypothesize that variant UGT1A1 genotypes reduce the risk for NAFLD development.
Methods: Two hundred thirty-four obese children 6 to 13 years of age were recruited. NAFLD was determined through liver ultrasonography. The UGT1A1 genotypes UGT1A1*6 and UGT1A1*28 were detected. We assessed the effects of UGT1A1 genotypes on pediatric NAFLD.
Results: In total, 12% of the obese children had NAFLD. The subjects with NAFLD had lower serum total bilirubin levels (0.25 +/- 0.30 mg/dL) than did those without NAFLD (0.36 +/- 0.38 mg/dL; P = .021). With conditioning on the effects of age- and gender-adjusted BMI, waist/hip ratio, and adiponectin levels, variant UGT1A1*6 genotypes were a protecting factor for NAFLD, with an estimated adjusted odds ratio of 0.31 (95% confidence interval: 0.11-0.91; P = .033), but variant UGT1A1*28 genotypes were not significantly associated with the occurrence of NAFLD.
Conclusions: Variant UGT1A1*6 genotypes are associated with a lower risk of NAFLD in obese Taiwanese children. The UGT1A1 genotype is a new risk factor for pediatric NAFLD.
Similar articles
-
A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.J Pediatr. 2011 May;158(5):740-4. doi: 10.1016/j.jpeds.2010.11.016. Epub 2010 Dec 18. J Pediatr. 2011. PMID: 21168155
-
Antioxidant effect of bilirubin and pediatric nonalcoholic fatty liver disease.Pediatrics. 2009 Dec;124(6):e1240-1. doi: 10.1542/peds.2009-2487. Pediatrics. 2009. PMID: 19948622 No abstract available.
-
Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.PLoS One. 2014 Jun 5;9(6):e98467. doi: 10.1371/journal.pone.0098467. eCollection 2014. PLoS One. 2014. PMID: 24901842 Free PMC article.
-
Imaging Modalities in Pediatric NAFLD.Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):200-208. doi: 10.1002/cld.994. eCollection 2021 Mar. Clin Liver Dis (Hoboken). 2021. PMID: 33868666 Free PMC article. Review. No abstract available.
-
Diagnostic and Treatment Dilemmas in Pediatric NAFLD.Clin Liver Dis (Hoboken). 2021 Aug 30;18(1):37-39. doi: 10.1002/cld.1085. eCollection 2021 Jul. Clin Liver Dis (Hoboken). 2021. PMID: 34484703 Free PMC article. Review. No abstract available.
Cited by
-
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.Int J Mol Sci. 2016 Jun 15;17(6):947. doi: 10.3390/ijms17060947. Int J Mol Sci. 2016. PMID: 27314342 Free PMC article. Review.
-
Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.Eur J Epidemiol. 2020 Feb;35(2):123-137. doi: 10.1007/s10654-019-00589-0. Epub 2019 Nov 26. Eur J Epidemiol. 2020. PMID: 31773475 Free PMC article.
-
Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.Clin Mol Hepatol. 2012 Dec;18(4):357-9. doi: 10.3350/cmh.2012.18.4.357. Epub 2012 Dec 21. Clin Mol Hepatol. 2012. PMID: 23323250 Free PMC article. No abstract available.
-
Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children.J Clin Med. 2021 Jun 25;10(13):2812. doi: 10.3390/jcm10132812. J Clin Med. 2021. PMID: 34202304 Free PMC article.
-
DetoxiProt: an integrated database for detoxification proteins.BMC Genomics. 2011 Nov 30;12 Suppl 3(Suppl 3):S2. doi: 10.1186/1471-2164-12-S3-S2. Epub 2011 Nov 30. BMC Genomics. 2011. PMID: 22369658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources